Eliel Bayever,Sarah F. Blanchette,Jonathan Basil Fitzgerald,Daniel F. Gaddy,Bart S. Hendriks,Ashish Kalra,Helen Lee
申请号：
US15809815
公开号：
US20180078556A1
申请日:
2017.11.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
